ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 040047952. A total of 3 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,738,000 | -27.7% | 4,149 | +1.1% | 0.07% | -35.0% |
| Q2 2014 | $2,404,000 | +38.5% | 4,102 | +48.8% | 0.10% | +6.2% |
| Q1 2014 | $1,736,000 | -59.5% | 2,756 | -62.4% | 0.10% | -64.5% |
| Q4 2013 | $4,283,000 | +193.6% | 7,322 | +164.4% | 0.27% | +187.4% |
| Q3 2013 | $1,459,000 | -79.8% | 2,769 | -70.5% | 0.10% | -80.3% |
| Q2 2013 | $7,236,000 | – | 9,398 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9,398 | $7,236,000 | 0.48% |
| GROUP ONE TRADING, L.P. | 902,200 | $6,947,000 | 0.17% |
| Citadel Advisors | 330,700 | $2,546,000 | 0.00% |